A 28-year-old female patient presented with a complaint of gingival hyperplasia (GH). The patient has diagnosed with chronic renal failure due to focal segmental glomerulosclerosis. She had a renal transplant eight months before admission to our hospital. The patient was using tacrolimus (TcR) 9 g/day, mycophenolate mofetil 720 mg/ day, prednisolone 5 mg/day, lansoprazol 40 mg/ day. She did not use nifedipine or phenytoin. Physical examination revealed GH ( Fig. 1) , but there were no other pathologies. General systemic examination and laboratory tests were normal. The blood TcR level was 11 ng/ml (normal range: 5-20 ng/ml). TcR was interrupted and switched to everolimus. It was observed that GH improved after one month in the outpatient clinic (Fig. 2) .
GH occurs as unwanted side effects of the drugs. These drugs are usually immunosuppressants (such as cyclosporin A (CsA) and TcR), calcium channel blockers (nifedipine) and anticonvulsants (phenytoin) [1] . CsA-induced GH was found more frequently than TcR. There are even studies showing that TcR does not cause GH alone [2, 3] . When CsA-induced GH is developed, it is shown that GH is reduced if CsA is replaced by TcR [4] . In our case, TcR-induced GH was switched to everolimus, and GH regressed. 
